Document Detail


Twenty-four hour changes in active and inactive renin after various oral doses of the converting enzyme inhibitor ramipril (HOE498) in normal man.
MedLine Citation:
PMID:  3023553     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Different oral doses (5, 20, 50 mg) of the new orally active nonsulfhydryl-converting enzyme inhibitor, ramipril (HOE498), were given to 12 normotensive healthy males, and the pattern of changes in plasma active and inactive renin concentration was evaluated. Active and inactive renin increased after ramipril, and the magnitude of the response was clearly dose related. Active renin rose markedly by 4 hours and tended to decrease thereafter, although remaining higher than basal at 24 hours. In contrast, inactive renin rose more slowly, and the increase was sustained throughout the 24-hour period. The pattern of these changes is consistent with the hypothesis that circulating inactive renin is a biosynthetic precursor of the active form.
Authors:
L S Malatino; P Manhem; S G Ball; B J Leckie; J J Morton; G D Murray; J I Robertson
Related Documents :
8165703 - Correction of posttransplant erythrocytosis with enalapril.
22574883 - Impact of nonlinear midazolam pharmacokinetics on the magnitude of the midazolam-ketoco...
9726693 - Pharmacokinetics of dexibuprofen administered as 200 mg and 400 mg film-coated tablets ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Journal of clinical hypertension     Volume:  2     ISSN:  0748-450X     ISO Abbreviation:  J Clin Hypertens     Publication Date:  1986 Sep 
Date Detail:
Created Date:  1987-01-08     Completed Date:  1987-01-08     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8510461     Medline TA:  J Clin Hypertens     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  231-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Oral
Adult
Angiotensin I / blood
Angiotensin II / blood
Angiotensin-Converting Enzyme Inhibitors*
Bicyclo Compounds / pharmacology*
Blood Pressure / drug effects
Bridged Compounds / pharmacology*
Dose-Response Relationship, Drug
Humans
Male
Ramipril
Renin / blood*
Chemical
Reg. No./Substance:
0/Angiotensin-Converting Enzyme Inhibitors; 0/Bicyclo Compounds; 0/Bridged Compounds; 11128-99-7/Angiotensin II; 87333-19-5/Ramipril; 9041-90-1/Angiotensin I; EC 3.4.23.15/Renin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Visual evoked potentials in parkinsonism and dopamine blockade reveal a stimulus-dependent dopamine ...
Next Document:  Acute renal effects of captopril in patients with congestive heart failure.